• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扶正消癥方通过调控 circRNA-miRNA-mRNA 网络改善脂糖代谢发挥抗肝癌作用。

Fuzheng Xiaozheng prescription exerts anti-hepatocellular carcinoma effects by improving lipid and glucose metabolisms via regulating circRNA-miRNA-mRNA networks.

机构信息

School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.

Sichuan Provincial Key Laboratory for Development and Utilization of Characteristic Horticultural Biological Resources, College of Chemistry and Life Sciences, Chengdu Normal University, Chengdu, 611130, China.

出版信息

Phytomedicine. 2022 Aug;103:154226. doi: 10.1016/j.phymed.2022.154226. Epub 2022 Jun 1.

DOI:10.1016/j.phymed.2022.154226
PMID:35689900
Abstract

BACKGROUND

Hepatocellular carcinoma (HCC) is a major threat to human health due to its high lethality. Our previous studies suggested that Fuzheng Xiaozheng prescription (FZXZP), an effective Chinese medicine, demonstrated significant suppressive effects on HCC. However, its underlying mechanism remains largely unclear.

PURPOSE

This study aimed to investigate the anti-HCC mechanisms of FZXZP from transcriptomic sequencing based on a holistic perspective.

METHODS

Rat HCC model was induced by diethylnitrosamine, and then the model was administered with two doses of FZXZP, high and low. Sodium demethylcantharidate was used as a positive control. Subsequently, microarrays of circRNA, miRNA and mRNA were performed on the blank, model, high and low dose groups, respectively, and the competitive binding mechanisms among them were further analyzed by bioinformatics. Then, the circRNA-miRNA-mRNA networks were constructed to mine the targeted-RNAs of FZXZP in HCC, as well as to explore their potential regulatory mechanisms. Finally, functions and pathways of the FZXZP targeted genes in rat HCC were annotated with GO and KEGG, and qRT-PCR was performed to validate the accuracy of the above analyses in this study.

RESULTS

The results showed that FZXZP significantly inhibited the development and progression of HCC in rats, improved the pathological conditions and suppressed the proliferation of HCC cells. Subsequently, after a series of screening, the competing endogenous RNA networks (circRNA-miRNA-mRNA), consisting of 2 circRNAs, 7 miRNAs and 104 mRNAs, were finally established. KEGG and GO analyses of the networks revealed that lipid metabolism related pathways, such as fatty acid metabolism, bile secretion and PPAR pathway, were significantly enriched. In the further hubgene network analysis, in addition to lipid metabolism, aberrant glucose metabolism was found to be ameliorated by G6pc and Pklr in hubgenes. Finally, the qRT-PCR analyses confirmed that the expression tendencies of the above targeted genes were correct and believable in transcriptomic sequencings, and qRT-PCR results of the genes closely related to proliferation, invasion and apoptosis of HCC also indicated the inhibitory effects of FZXZP on HCC obviously.

CONCLUSION

FZXZP demonstrated significant anti-HCC effects through improving lipid and glucose metabolism, restoring the metabolic homeostasis of the liver via circRNA-miRNA-mRNA networks.

摘要

背景

肝细胞癌(HCC)因其高致死率而成为严重威胁人类健康的主要疾病。我们之前的研究表明,扶正消症方(FZXZP)作为一种有效的中药,对 HCC 具有显著的抑制作用。然而,其潜在机制仍不清楚。

目的

本研究从整体角度出发,通过转录组测序探讨 FZXZP 的抗 HCC 机制。

方法

采用二乙基亚硝胺诱导大鼠 HCC 模型,然后给予 FZXZP 高、低两种剂量治疗,阳性对照药为去甲斑蝥酸钠。分别对空白组、模型组、高剂量组和低剂量组进行 microarray 检测,对 circRNA、miRNA 和 mRNA 进行检测,然后通过生物信息学分析其竞争结合机制。进一步构建 circRNA-miRNA-mRNA 网络,挖掘 FZXZP 在 HCC 中的靶向 RNA,并探讨其潜在的调控机制。最后,对 FZXZP 靶向基因在大鼠 HCC 中的功能和通路进行注释,GO 和 KEGG 分析,采用 qRT-PCR 对上述分析在本研究中的准确性进行验证。

结果

结果表明,FZXZP 能显著抑制大鼠 HCC 的发生发展,改善病理状况,抑制 HCC 细胞增殖。随后,经过一系列筛选,最终建立了由 2 个 circRNA、7 个 miRNA 和 104 个 mRNA 组成的竞争性内源性 RNA 网络(circRNA-miRNA-mRNA)。对网络进行 KEGG 和 GO 分析发现,脂肪酸代谢、胆汁分泌和 PPAR 通路等脂质代谢相关通路显著富集。在进一步的 hubgene 网络分析中,除脂质代谢外,还发现 hubgenes 中的 G6pc 和 Pklr 改善了异常的葡萄糖代谢。最后,qRT-PCR 分析证实了上述靶向基因在转录组测序中的表达趋势是正确和可信的,与 HCC 增殖、侵袭和凋亡密切相关的基因 qRT-PCR 结果也表明 FZXZP 对 HCC 有明显的抑制作用。

结论

FZXZP 通过改善脂质和葡萄糖代谢,通过 circRNA-miRNA-mRNA 网络恢复肝脏代谢平衡,发挥显著的抗 HCC 作用。

相似文献

1
Fuzheng Xiaozheng prescription exerts anti-hepatocellular carcinoma effects by improving lipid and glucose metabolisms via regulating circRNA-miRNA-mRNA networks.扶正消癥方通过调控 circRNA-miRNA-mRNA 网络改善脂糖代谢发挥抗肝癌作用。
Phytomedicine. 2022 Aug;103:154226. doi: 10.1016/j.phymed.2022.154226. Epub 2022 Jun 1.
2
Fuzheng Xiaozheng prescription relieves rat hepatocellular carcinoma through improving anti-inflammation capacity and regulating lipid related metabolisms.扶正消癥方通过改善抗炎能力和调节脂质相关代谢缓解大鼠肝癌。
J Ethnopharmacol. 2022 Feb 10;284:114801. doi: 10.1016/j.jep.2021.114801. Epub 2021 Nov 5.
3
Anti-hepatocellular carcinoma efficacy of Fuzheng Xiaozheng prescription and its interventional mechanism studies.扶正消症方抗肝癌的疗效及其介入机制研究。
J Ethnopharmacol. 2022 Mar 1;285:114913. doi: 10.1016/j.jep.2021.114913. Epub 2021 Dec 12.
4
Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Hepatocellular Carcinoma by Integrated Microarray Analysis.通过综合微阵列分析鉴定肝细胞癌中潜在的功能性环状RNA-微小RNA-信使RNA调控网络
Med Sci Monit Basic Res. 2018 Apr 30;24:70-78. doi: 10.12659/MSMBR.909737.
5
Knockdown and Overexpression Experiments to Investigate the Inhibitory Mechanism of Fuzheng Xiaozheng Prescription, an Effective Chinese Herbal Formula for the Clinical Treatment of Hepatocellular Carcinoma.敲低和过表达实验以探究扶正消症方(一种用于临床治疗肝细胞癌的有效中药方剂)的抑制机制
Pharmaceuticals (Basel). 2024 Aug 31;17(9):1159. doi: 10.3390/ph17091159.
6
CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.环状 CCNA1 沉默作为 miR-106b-5p 的海绵吸附物抑制 GPM6A 表达,通过增强 DYNC1I1 表达和激活 AKT/ERK 信号通路促进 HCC 进展。
Int J Biol Sci. 2022 Jan 1;18(2):637-651. doi: 10.7150/ijbs.66915. eCollection 2022.
7
A circRNA-miRNA-mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma.环状 RNA-miRNA-mRNA 网络鉴定探索肝细胞癌的潜在发病机制和治疗策略。
J Transl Med. 2018 Aug 9;16(1):220. doi: 10.1186/s12967-018-1593-5.
8
Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.全面分析竞争性内源性 circRNA-lncRNA-miRNA-mRNA 网络,并鉴定肝癌的新型潜在生物标志物。
Aging (Albany NY). 2021 May 28;13(12):15990-16008. doi: 10.18632/aging.203056.
9
High-throughput circular RNA sequencing reveals the profiles of circular RNA in non-cirrhotic hepatocellular carcinoma.高通量环状 RNA 测序揭示非肝硬化肝癌中环状 RNA 的特征。
BMC Cancer. 2022 Aug 5;22(1):857. doi: 10.1186/s12885-022-09909-2.
10
Identification of circular RNA-microRNA-messenger RNA regulatory network in hepatocellular carcinoma by integrated analysis.通过整合分析鉴定肝癌中的环状 RNA-微小 RNA-信使 RNA 调控网络。
J Gastroenterol Hepatol. 2020 Jan;35(1):157-164. doi: 10.1111/jgh.14762. Epub 2019 Jul 18.

引用本文的文献

1
The tumor microenvironment in hepatocellular carcinoma: mechanistic insights and therapeutic potential of traditional Chinese medicine.肝细胞癌中的肿瘤微环境:中医的机制见解与治疗潜力
Mol Cancer. 2025 Jun 10;24(1):173. doi: 10.1186/s12943-025-02378-8.
2
Research advances in traditional Chinese medicine formulae and active components targeting lipid metabolism for hepatocellular carcinoma therapy.用于肝细胞癌治疗的靶向脂质代谢的中药方剂及活性成分的研究进展
Front Pharmacol. 2025 Apr 25;16:1528671. doi: 10.3389/fphar.2025.1528671. eCollection 2025.
3
Ginseng and its functional components in non-alcoholic fatty liver disease: therapeutic effects and multi-target pharmacological mechanisms.
人参及其功能成分在非酒精性脂肪性肝病中的治疗作用及多靶点药理机制
Front Pharmacol. 2025 Apr 9;16:1540255. doi: 10.3389/fphar.2025.1540255. eCollection 2025.
4
Knockdown and Overexpression Experiments to Investigate the Inhibitory Mechanism of Fuzheng Xiaozheng Prescription, an Effective Chinese Herbal Formula for the Clinical Treatment of Hepatocellular Carcinoma.敲低和过表达实验以探究扶正消症方(一种用于临床治疗肝细胞癌的有效中药方剂)的抑制机制
Pharmaceuticals (Basel). 2024 Aug 31;17(9):1159. doi: 10.3390/ph17091159.
5
The role of competing endogenous RNA network in the development of hepatocellular carcinoma: potential therapeutic targets.竞争性内源性RNA网络在肝细胞癌发生发展中的作用:潜在治疗靶点
Front Cell Dev Biol. 2024 Jan 31;12:1341999. doi: 10.3389/fcell.2024.1341999. eCollection 2024.